ロード中...

Personalized one-two punches for lung cancer

Discovery of individualized therapies to address resistance to tyrosine kinase inhibitors (TKIs) has been hampered by the inability to test drug combinations on patient samples before and after TKI resistance. A recent study published in Science by Crystal et al. describes a methodology for pharmaco...

詳細記述

保存先:
書誌詳細
出版年:Cell Res
主要な著者: Scarborough, Hannah A, Bunn, Paul A, DeGregori, James
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4349242/
https://ncbi.nlm.nih.gov/pubmed/25547118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cr.2014.168
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!